Audit 398814

FY End
2025-08-31
Total Expended
$21.52M
Findings
70
Programs
16
Organization: Vivent Health and Affiliates (WI)
Year: 2025 Accepted: 2026-04-15

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1206688 2025-001 Material Weakness Yes B
1206689 2025-001 Material Weakness Yes B
1206690 2025-001 Material Weakness Yes B
1206691 2025-001 Material Weakness Yes B
1206692 2025-001 Material Weakness Yes B
1206693 2025-001 Material Weakness Yes B
1206694 2025-001 Material Weakness Yes B
1206695 2025-001 Material Weakness Yes B
1206696 2025-001 Material Weakness Yes B
1206697 2025-001 Material Weakness Yes B
1206698 2025-001 Material Weakness Yes B
1206699 2025-001 Material Weakness Yes B
1206700 2025-001 Material Weakness Yes B
1206701 2025-001 Material Weakness Yes B
1206702 2025-001 Material Weakness Yes B
1206703 2025-001 Material Weakness Yes B
1206704 2025-001 Material Weakness Yes B
1206705 2025-001 Material Weakness Yes B
1206706 2025-001 Material Weakness Yes B
1206707 2025-001 Material Weakness Yes B
1206708 2025-001 Material Weakness Yes B
1206709 2025-001 Material Weakness Yes B
1206710 2025-001 Material Weakness Yes B
1206711 2025-001 Material Weakness Yes B
1206712 2025-001 Material Weakness Yes B
1206713 2025-001 Material Weakness Yes B
1206714 2025-001 Material Weakness Yes B
1206715 2025-001 Material Weakness Yes B
1206716 2025-001 Material Weakness Yes B
1206717 2025-001 Material Weakness Yes B
1206718 2025-001 Material Weakness Yes B
1206719 2025-001 Material Weakness Yes B
1206720 2025-001 Material Weakness Yes B
1206721 2025-001 Material Weakness Yes B
1206722 2025-001 Material Weakness Yes B
1206723 2025-001 Material Weakness Yes B
1206724 2025-001 Material Weakness Yes B
1206725 2025-001 Material Weakness Yes B
1206726 2025-001 Material Weakness Yes B
1206727 2025-001 Material Weakness Yes B
1206728 2025-001 Material Weakness Yes B
1206729 2025-001 Material Weakness Yes B
1206730 2025-001 Material Weakness Yes B
1206731 2025-001 Material Weakness Yes B
1206732 2025-001 Material Weakness Yes B
1206733 2025-001 Material Weakness Yes B
1206734 2025-001 Material Weakness Yes B
1206735 2025-001 Material Weakness Yes B
1206736 2025-001 Material Weakness Yes B
1206737 2025-001 Material Weakness Yes B
1206738 2025-001 Material Weakness Yes B
1206739 2025-001 Material Weakness Yes B
1206740 2025-001 Material Weakness Yes B
1206741 2025-001 Material Weakness Yes B
1206742 2025-001 Material Weakness Yes B
1206743 2025-001 Material Weakness Yes B
1206744 2025-001 Material Weakness Yes B
1206745 2025-001 Material Weakness Yes B
1206746 2025-001 Material Weakness Yes B
1206747 2025-001 Material Weakness Yes B
1206748 2025-001 Material Weakness Yes B
1206749 2025-001 Material Weakness Yes B
1206750 2025-001 Material Weakness Yes B
1206751 2025-001 Material Weakness Yes B
1206752 2025-001 Material Weakness Yes B
1206753 2025-001 Material Weakness Yes B
1206754 2025-001 Material Weakness Yes B
1206755 2025-001 Material Weakness Yes B
1206756 2025-001 Material Weakness Yes B
1206757 2025-001 Material Weakness Yes B

Contacts

Name Title Type
EM7PFJBH81E1 Erin Crandall Auditee
3108809955 Krista Pankop, CPA Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal and state awards (the schedule) includes the federal and state award activity of Vivent Health and Affiliates (the Organization) under programs of the federal and state governments for the year ended August 31, 2025. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance) and the Wisconsin State Single Audit Guidelines (the Guidelines). Because the schedule presents only a selected portion of the operations of the Organization, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Organization. Management reviews the expenditures of federal and state awards for each entity that comprises the Organization and determines if a separate audit is required under the Uniform Guidance. Expenditures for the following consolidated subsidiaries of the Organization are not included in the accompanying schedule of expenditures of federal and state awards to meet the requirements of the Uniform Guidance because they either are subject to a stand-alone audit requirement or did not receive any funding subject to the Uniform Guidance or the Guidelines: Milwaukee AIDS Housing Corporation, Inc. Vivent Health Pharmacy, LLC Vivent Endowment Fund, Inc. CARES Pharmacy, LLC EFA Pharmacy, LLC AIDS Services of Austin Pharmacy, LLC Vivent Pharmacy Illinois, LLC Vivent Pharmacy Michigan, LLC
The direct state of Texas funding received by the Organization was less than $750,000 during the year ended August 31, 2025. Total funds received directly from the state of Texas was $350,500 for the year ended August 31, 2025.

Finding Details

Agency: All Assistance Listing Number and State ID: All Programs: All Statement of Condition: The Organization's controls did not detect that reimbursement was received for the same expenditure in the prior and the current grant period. Criteria: Organizations are responsible for designing, implementing and maintaining internal control over compliance for allowable costs. Questioned Costs: See finding 2025-02. Context: The Organization had an instance of noncompliance with allowable costs and the controls in place did not detect the error. Effect: Noncompliance with allowable costs went undetected due to a lack of effective controls over voided and reissued checks. Cause: The Organization voided and reissued a check. Due to this an expense was reimbursed by a government agency in two fiscal years. Although the amount was not material current controls did not detect the error which led to noncompliance. Recommendation: We recommend management review their controls surrounding allowable costs, specifically in instances when expenses are voided and rebooked. This will ensure expenditures are charged to grants in the effective grant period. Management's Response: Management reviewed this instance and performed a detailed analysis of our internal controls, procedures and other like transactions. Management concluded that it was an isolated incident that occurred due to the timing and processing of the voided transaction and the transition to a new grant year. Vivent Health has implemented additional controls including dual review of grant year-to-date expenditures and system and reporting enhancements that will identify and prevent changes related to prior periods